Spence Paul Jr. 4
4 · OptiNose, Inc. · Filed Dec 15, 2022
Insider Transaction Report
Form 4
OptiNose, Inc.OPTN
Spence Paul Jr.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-15+500,000→ 500,000 totalExercise: $1.75Exp: 2032-12-15→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period commencing on December 15, 2022. Twenty-five percent (25%) of the option vests and becomes exercisable on December 15, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.